Otonomy Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear.
| Website: | www.otonomy.com |
| Main Phone: | +1 858 242-5200 |
| Address: | 6275 Nancy Ridge Drive |
| Address 2: | Suite 100 |
| State: | CA |
| City / Town: | San Diego |
| Country: | USA |
| Postal Code: | 92121 |
| Exchange: | NGS |
| Employees: | 131 |
| NAICS: | Pharmaceutical P |
| Last Price 20.50 | Change $ 0.15 | Change % 0.74 | Tick N/A |
| Bid 20.25 | Bid Size 400.00 | Ask 20.45 | Ask Size 200.00 |
| Open 20.40 | High 20.55 | Low 20.25 | Prev Close 20.35 |
| Last Trade | Volume 18,824 | 52 Wk Hi 20.65 | 52 Wk Low 11.30 |
| Market Cap 621.2 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 30,303,410.00 | EPS (TTM) -3.45 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 46 |
| Number of Buys | 0 | 17 |
| Number of Sells | 0 | 29 |
| Net Activity | 0 | -407757 |
| Last 10 Buys | Shares |
|---|---|
| Vickie L. Capps | 1,000 |
| Vickie L. Capps | 1,000 |
| Jay Lichter | 1,000 |
| Chau Q. Khuong | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Carl LeBel | 1,000 |
| Carl LeBel | 1,000 |
| Paul E. Cayer | 1,000 |
| Paul E. Cayer | 1,000 |
| David A. Weber | 1,000 |
| Robert M. Savel | 1,000 |
| Robert M. Savel | 1,000 |
| Robert M. Savel | 1,000 |
| Robert M. Savel | 1,000 |
| Chau Q. Khuong | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 55 | 55 | 55 | 55 |
| Low Target Price Estimate | 28 | 28 | 28 | 28 |
| Mean Target Price Estimate | 39.6 | 39.6 | 39.6 | 39 |
| Standard Deviation | 10.45 | 10.45 | 10.45 | 11.97 |
| Date of Most Recent Estimate | 08/05/16 | 08/05/16 | 06/03/16 | 08/18/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-04 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-08-04 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 66 | 2016-08-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 14 | 2016-08-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-21 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1.4 | 1.4 | 1.4 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
